A survey of the expression of the multidrugresistance gene (mdr) in mouse tissues revealed that a mdr mRNA species is expressed at extremely high levels in the gravid uterus. mdr mRNA expression levels increase dramatically during pregnancy compared to the relatively low levels of expression observed in the nongravid uterus. In situ hybridization experiments revealed that the increased expression of the mdr mRNA is specifically localized to the secretory epithelial cells of the endometrium. Immunocytochemistry studies with a mdr glycoprotein-specific antiserum demonstrate that the mdr glycoprotein is predominantly localized to the luminal surface of the secretory epithelial cells. These results indicate that the mdr gene expression in the uterus is controlled by the physiologic changes associated with pregnancy. Our data are consistent with a potential role for the mdr glycoprotein in the transport of substrate across the secretory epithelium of the gravid uterus.
Resistance of malignant neoplasms to multiple chemotherapeutic agents is a major cause of treatment failure. Tumors initially sensitive to cytotoxic agents often recur and are refractory to multiple chemotherapeutic drugs (1) . It has been inherently difficult to study such drug resistance in vivo. However, a number of highly resistant cell lines have been isolated in vitro by stepwise selection with single chemotherapeutic agents. These cell lines are often also resistant to multiple other structurally and functionally unrelated cytotoxic agents (2) (3) (4) (5) (6) . Characteristic of such highly resistant cell lines is the amplification of a small group of closely related genes, termed mdr for multiple drug resistance (7) (8) (9) (10) .
We and others have previously isolated from murine, hamster, and human cell lines cDNA clones complementary to members of the mdr gene family (7) (8) (9) (10) (11) (12) (13) (14) . The mdr phenotype can be conveyed by the transfection of murine (10) and human (15) mdr cDNA. The complete nucleotide sequence of the mdr cDNA (11, 13) indicates that it encodes a 140-kDa polypeptide similar or identical to the P-glycoprotein, a 170-kDa membrane glycoprotein, which has consistently been shown to be overexpressed in mdr cell lines (16) . A high degree of evolutionary conservation in structure suggests that members of this gene family play a significant role in normal physiologic processes. Striking similarity to a series of bacterial transport genes suggests that members of this gene family play a role in normal transport processes (11, 13, 17) .
Analysis ofthe tissue distribution of mdr expression should provide important clues to the normal physiological function of the mdr P-glycoprotein. Recent studies have analyzed the tissue-speciflic distribution of mdr transcription from various human tissues where adrenal, kidney, and colon were identified as sites of elevated mdr expression (18) . In addition, increased levels of mdr expression have been observed in regenerating rat liver (19) . Because extraction of RNA from whole tissues is limited in determining the precise cell types expressing a particular mRNA, we chose in situ hybridization to systematically survey the cellular distribution of mdr mRNA in mouse tissues. In the course of this survey, we identified a tissue, the secretory epithelium of the gravid uterus, in which the pattern and level of expression of mdr transcripts were so marked that an in-depth analysis of mdr expression in this tissue was undertaken.
We observed that in the mouse there are extremely high levels of mdr gene expression during pregnancy in the secretory glandular epithelium of the endometrium of the uterus, a tissue engaged in high levels of secretory activity (20) hybridization under siliconized coverslips at 450C for 12 hr in air-tight moist chambers (22) .
The [32P]CTP-labeled antisense RNA probe used to detect mdr mRNA was transcribed by using the SP6 polymerase from pcDR1.3 (10), a 1300-base insert representing the middle third of the murine cDNA, ADR11 cloned into the plasmid pGEM (Promega Biotec, Madison, WI). Full-length transcripts were purified and alkaline-hydrolyzed to a mean size of 150 bases (22) . Specific activity was =1 x 109 cpm/,g. As a control for nonspecific binding of probe to tissue sections, identically labeled and sized run-off RNA transcripts from a cloned fragment of bacteriophage A were simultaneously hybridized to alternate tissue sections. Probe concentrations were 0.15 ,ug/ml in a total hybridization vol of 25 1ul. After hybridization, slides were washed in 2 x SSC/50%o formamide at 450C and then in 2 x SSC prior to soaking in 2 x SSC plus 0.5% Triton X-100 at 450C for 30 min. The sections were then treated with pancreatic RNase A (50 jug/ml) in 2 x SSC at 370C for 1 hr. After soaking overnight at 370C in 2 x SSC, slides were dehydrated and coated with NTB-2 emulsion. Slides were developed in D19 (Eastman Kodak) and stained with hematoxylin/eosin prior to photomicrographic analysis.
RNA Isolation and RNA Blot Hybridization. After tissue dissection or harvesting of cell lines, total RNA was isolated by using guanidine hydrochloride (23) and then electrophoresed in a 1.0% agarose formaldehyde gel. After electroblotting to GeneScreenPlus (New England Nuclear), the RNAs were hybridized to [32P]dCTP-labeled pcDR1.3 insert (24) . Hybridization was performed as described (9) and a LKB Ultrascan was used for densitometric analysis. The membrane was reprobed with a mouse actin cDNA for normalization of RNA loading.
Immunocytochemistry. Rabbit antiserum was raised against polyacrylamide gel-purified mdr glycoprotein present in vinblastine-resistant J774.2 mouse cells as described (25) . covered with 100 ,ul of a 1:100 dilution of the mdr-specific rabbit antiserum, preimmune serum, or a von Willebrand factor-specific rabbit antiserum (Dakopatts, Copenhagen). Incubation was for 60 min at room temperature in humidified air-tight chambers. After three 5-min washes in TBS, the sections were covered with a 1:250 dilution ofgoat anti-rabbit alkaline phosphatase conjugate (Promega Biotec) for 60 min at room temperature. After three 5-min washes in TBS, the slides were covered for 20 min with the fast-red TR salt color substrate I (Dakopatts) for the alkaline phosphatase. They were rinsed briefly with TBS and then tap water before counterstaining with hematoxylin. RESULTS In Situ Hybridization Localiation of mdr mRNA in the Endometrium. Fig. 1 shows bright-field and dark-field photomicrographs of in situ hybridization to tissue sections of gestation day-15 uterus with a radiolabeled mdr RNA probe and an identically labeled and sized control for nonspecific tissue binding. The uterine cavity, depicted in the bright-field photomicrographs ( Fig. 1 a and c) , is lined by secretory columnar epithelial cells, which are contiguous with the hypertrophied and convoluted, endometrial glandular structures. The dark-field photomicrograph (Fig. lb) demonstrates specific localization and high levels of expression of mdr transcripts to the secretory, columnar epithelium. The hybridization signal was observed in the secretory columnar epithelial cells throughout the uterine cavity. The secretory epithelial cells of the endometrial glands also showed markedly increased mdr mRNA expression, although some of the smaller glandular structures located farthest from the endometrial cavity displayed low to nondetectable levels of hybridization. Specific hybridization is not seen when the control probe is used (Fig. ld) . A comparable hybridization signal was not observed with either the mdr-specific RNA probe or control probe on tissue sections of nongravid uterus (see below). Fig. 2 shows in situ hybridization results at higher magnification with mdr-specific and control probes on sections of nongravid uterus as well as uterus from gestational days 8 and 15. Fig. 2 a and (Fig. 2 d and f) .
RNA Blot Analysis of mdr mRNA Expression. To evaluate the RNA species hybridizing to the mdr-specific probe, RNA isolated from the uterus at different times during gestation was fractionated by agarose gel electrophoresis (Fig. 3) . Low levels of an =5-kilobase mRNA species are observed in the nongravid uterus. This mRNA species is equivalent in size to mdr mRNA detected in the L1210 mouse leukemia cell line and L1210 DN, a mdr derivative of that leukemia cell line. By gestation day 14, the mdr mRNA has increased dramatically and reaches a peak by gestation day 16. By gestation day 19, shortly before parturition, there is a slight decrease in mdr mRNA from the uterus. The peak levels of mdr mRNA observed in the gravid uterus are =10 times the amount seen in the highly mdr L1210 DN cell line. These values are likely to underestimate the level of expression in uterine secretory epithelium since the RNA preparations were derived from total uterus, which contains multiple cell types, many of which express low amounts of mdr mRNA (Figs. 1 and 2 ). In fact, in situ hybridization indicates that by gestation day 8 there is already a significant increase in mdr mRNA in the secretory epithelium of the endometrium, whereas this celltype-specific increase is not apparent by RNA blot analysis (Fig. 3) . Southern blot analysis demonstrated that the mdr gene is not amplified in uterine tissue DNA (data not shown).
Immunocytochemical with respect to their histologic orientation within tissue. Their nucleus is displaced toward the basilar side of the cell. At the opposite side is the luminal surface across which secretory events take place. Because of this structural asymmetry of the epithelial cells and the possible role of mdr glycoprotein in transmembrane transport, we used immunocytochemistry with a rabbit antiserum specific for mdr glycoprotein. Fig. 4a shows that the antiserum to the mdr glycoprotein preferentially binds to the columnar secretory epithelium in the day-15 gestational uterus. This binding is localized primarily at the luminal surface. No comparable localized binding was observed in these cells in nongravid uterus (data not shown). Preimmune serum did not show any specific binding to the secretory epithelial cells in the gravid or nongravid uterus (data not shown). Fig. 4b shows that a rabbit antiserum specific for von Willebrand factor used as an immune serum control binds strictly to endothelial cells and does not bind to the columnar epithelial cells of the secretory glands. The specific localization of the mdr glycoprotein to the secretory cells in the pregnant uterus is consistent with a possible functional role for the mdr glycoprotein in transmembrane transport across the secretory surface of these epithelial cells.
DISCUSSION
The identification of the secretory epithelium of the gravid uterus as a major expression site of the mdr gene raises a number of intriguing questions. Could the mdr gene product be involved in the specific transport of one or more of the wide variety of substances secreted into the uterine lumen? The uterine glandular epithelium consists primarily of columnar secretory cells. These cells line the endometrial cavity and are known to be involved in transport of ions, sugars, free amino acids, and a number of glycoproteins into the uterine lumen (26, 27) . The endometrial derived secretions have been shown to play a role in influencing the growth and development of the embryo (26, 27) .
The predicted amino acid sequence of the mdr polypeptide shows extensive similarity to a number of bacterial transport proteins (11, 13, 17) . Several of these bacterial homologues are each part of a multicomponent periplasmic transport system that shuttles a wide range of substrates across the inner cell membrane (17) . The diverse range of substances include histidine, maltose, ribose, phosphate, and oligopeptides. Specificity is accomplished with unique substratebinding proteins, which also recognize the specific transport system. Hemolysin B, the bacterial transport polypeptide with the most extensive similarity to the mdr polypeptide, transports a specific protein, hemolysin toxin, across the outer cell membrane. The wide range of substrates from ions to specific proteins transported by proteins similar to the mdr glycoprotein is consistent with the concept that a single or multiple substrates are transported across the luminal surface of the secretory epithelium by the mdr glycoprotein. This would represent an alternative to the process of fusion of secretory granules with the cell membrane for the transport of specific peptides out of the cell in a manner analogous to hemolysin B. It is currently not known whether the mdr glycoprotein functions alone or in conjunction with other proteins that may convey specificity in a similar fashion to the bacterial transport systems.
Of particular interest are the embryocidal and growth retardation effects caused by verapamil during early gestation (28) . Previous studies have indicated that the mdr phenotype can be reversed by verapamil (29, 30 functions of the mdr gene product in the endometrial glandular epithelium. A reduction in certain components of the glandular secretions essential for placental and/or fetal maturation would therefore be predicted along with the resulting detrimental effect on embryo growth and development. On the other hand, one cannot rule out the possibility that the mdr glycoprotein localized to the luminal surface of the endometrial columnar epithelium is involved in the absorptive transport of substances from the endometrial cavity.
The mdr genes make up a multigene family. An important issue is which family member is expressed in the uterine glands. The probe used in the RNA blot analysis shown in Fig. 3 cross-hybridizes with both the ADR11 and ADR29 sequences, which represent related but distinct mdr cDNAs (10) . Transfection of DR11 has been shown to confer the mdr phenotype to drug-sensitive cells in culture (10) . Whether or not the ADR29 cDNA has the same properties has not yet been proven. RNA blot analysis with probes specific for ADR11 and ADR29 shows that the gestational uterine transcripts hybridize to the ADR11-specific probe but not to the AD29-specific probe (unpublished observations). These results suggest that the uterine mdr homologous mRNA is closely related or possibly identical to the mdr cDNA, which can confer mdr. Alternatively, the uterine mdr transcripts may represent yet another member of this locus. These possibilities suggest that different members of the mdr family may be specialized for function in specific cell types.
The localization of mdr glycoprotein to the luminal surface of the secretory glandular epithelium indicates that the mdr glycoprotein responds to mechanisms that control the subcellular localization of membrane proteins. Recent studies have localized the mdr glycoprotein to the apical surfaces of a number of secretory cells in human liver, pancreas, kidney, and intestine (31) . These data indicate that this sorting mechanism to the secretory surface of cells may be a general phenomenon for some of the members of the mdr glycoprotein family. They further suggest that the mdr glycoprotein may be involved in specialized secretory functions in different tissues. The relationship between the physiologic changes of pregnancy and the increased levels of mdr mRNA in the secretory glandular epithelium raises important questions about the control of mdr gene expression. The uterine secretory epithelium responds in a complex manner to the levels of estrogen and progesterone during pregnancy (32) . Our results suggest that these or other hormonal influences lead to the increased levels of mdr mRNA in the secretory epithelium of the gravid uterus. Furthermore, there must be a mechanism to increase mdr expression specific to the glandular epithelium, since the other tissues in the endometrium respond to the hormonal influences of pregnancy but do not increase mdr expression. The localization of increased mdr glycoprotein expression to the uterine glandular epithelium raises the possibility that mdr expression could be increased substantially in malignant cells derived from endometrial glandular epithelium. If increased expression of mdr is responsible for the drugresistant nature of advanced endometrial adenocarcinoma (33) or other malignancies in which hormonal influences may play a role in increasing mdr expression, then the use of strategies that may circumvent mdr would be indicated in such patients.
